The Noro-Moseley Approach

Since 1983, NMP has built deep domain expertise and curated a valuable network within the B2B technology and healthcare markets.

NMP Investment Criteria

  • Year-Over-Year Growth

    50%+

  • Compelling Unit Economics

  • Target Revenue Run Rate

    $ 2M-20M

  • $ 5-20M

    NMP Target Investment

  • Significant opportunity for market disruption

  • < $ 20M

    Minimal Prior Funding

CEO Testimonials

  • I have a high degree of trust in Noro-Moseley. They are great to work with, down to earth, honest, and entrepreneurial.

    Braxton Jarratt

    Former CEO of Clearleap (acquired by IBM in 2015)

  • My experience with NMP has been very positive. They helped us grow much faster as a company due to their support, advice, and connections.

    Wain Kellum

    Former CEO of Vocalocity (acquired by Vonage in 2013)

  • I wanted a partner who understood my vision. NMP was very supportive of me and pushed for alignment with the rest of the board.

    Erik Huddleston

    Former CEO of Trendkite (acquired by Cision in 2019)

  • We selected Noro-Moseley because we were looking for great human beings who believed in the vision and were interested in generating a great return while also having an impact.

    Michael Walsh

    CEO of Cariloop

  • NMP has added tremendous value beyond capital. They helped us put together a board of operators with $1B+ exits and guided us on our transition from services to SaaS.

    Dax Cross

    Co-founder of Revenue Analytics

where we focus

NMP invests in emerging technology and healthcare innovation hubs across the US

Healthcare Sector

45 million lives covered by NMP’s health plan investors

Healthcare

NMP partners with leading payers and health systems which cover 45 million lives across the US.